, Health and Social Care Committee
Gynaecological cancers: Panel 3
Diolch, Chair. I'm going to try and refrain from talking about data, because it's increasingly frustrating, but I do want to perhaps make, with permission, Chair, one suggestion on recommendations, because the word keeps coming back to me—and I hope it's…
, Plenary
Welsh Conservatives' Debate: The Coronation
I'm very grateful to have the opportunity to speak in today's debate, and proud to support the motion in front of us, marking a historic occasion, the coronation of His Majesty King Charles III. Saturday's occasion, Deputy Presiding Officer, will bring…
, Plenary
Debate on the Health and Social Care Committee Report—'Connecting the dots: tackling mental health inequalities in Wales'
Presiding Officer, when the Health and Social Care Committee in this Senedd was formed, the committee members undertook a piece of work to highlight what areas they would like to look at in the next five years, and this was one that I was really keen to see…
, Plenary
Questions to the Minister for Education and the Welsh Language
I'm grateful to the Minister for that answer. On Friday of last week, I visited Granada Material Handling Ltd in my constituency in Alyn and Deeside, who manufacture lifting equipment for a number of challenging applications sold across the globe. During my…
, Plenary
Questions to the Minister for Education and the Welsh Language
6. How is the Welsh Government ensuring that school leavers are equipped to take up manufacturing apprenticeships? OQ59439
, Plenary
Questions to the First Minister
I'm grateful to the First Minister for his answer. People need secure housing and that is exactly what council housing is. If we look over the border in England, they continue to sell off more social housing than is being built, putting people in incredibly…
, Plenary
Questions to the First Minister
3. What is the Welsh Government doing to increase the number of council houses in Wales? OQ59452
, Health and Social Care Committee
Gynaecological cancers: Panel 2
Thanks, Chair. The benefits of a healthy lifestyle are quite well-documented, I think, when it comes to cancers. Are there any specific risk factors when it comes to gynaecological cancers in particular? And then, if so, how do we ensure that there is…
, Health and Social Care Committee
Gynaecological cancers: Panel 2
Okay. That's—. We should look at that as well. Thank you. I'll leave it there, Chair.
, Health and Social Care Committee
Gynaecological cancers: Panel 2
Just very quickly, Chair, I understand the point being that the drug is funded but the services alongside that aren't funded. Is that the case in England?
, Health and Social Care Committee
Gynaecological cancers: Panel 2
I must say I haven't, but is there a case for a Welsh version of that?
, Health and Social Care Committee
Gynaecological cancers: Panel 2
—drugs fund.
, Health and Social Care Committee
Gynaecological cancers: Panel 2
Just to follow up then, I wonder—and you've explained really well the approach taken and NICE not accepting it or approving it, if you like, but the English, and it was the cancer—
, Health and Social Care Committee
Gynaecological cancers: Panel 2
—it'll be easier for me. We heard in the last session that it was nine years ago when that was introduced into England. It took a little bit longer to go into Scotland—I think it was seven years ago—and similar in Wales. But we also heard the funding—. It's…
, Health and Social Care Committee
Gynaecological cancers: Panel 2
Perhaps I will refer to it as its trade name, Avastin—
, Health and Social Care Committee
Gynaecological cancers: Panel 2
Thanks, Chair. I'm conscious of time, and my understanding is that it's the Chair's birthday as well, so pen-blwydd hapus, Chair, and just one question, perhaps, from me. Look, we've spoken a little bit about research and innovation in earlier questions, but…
, Health and Social Care Committee
Gynaecological cancers: Panel 1
There's that patch of acceptance that is there, but the funding—
, Health and Social Care Committee
Gynaecological cancers: Panel 1
Yes, and I think that's my point that I'm trying to get across. It would be interesting to see how many forms have been filled out, how many have been accepted and rejected, just for—. Because if a number have been accepted, it's coming out of the budget.
, Health and Social Care Committee
Gynaecological cancers: Panel 1
—to go and access funding from NHS Wales, essentially. So, it would be interesting to see how many patients have had—
, Health and Social Care Committee
Gynaecological cancers: Panel 1
Yes, I'm trying to get clarity on this. The drug's been available for nine years, approved and funded, in NHS England. And for loads of different reasons, the process between NHS England and NHS Wales—. I think we've seen it before, Chair, with cystic…
, Health and Social Care Committee
Gynaecological cancers: Panel 1
Thank you.
, Health and Social Care Committee
Gynaecological cancers: Panel 1
Thank you for that. We really must look at planning of workforce as a committee. We keep coming back to this.
, Health and Social Care Committee
Gynaecological cancers: Panel 1
'Yes' is the—
, Health and Social Care Committee
Gynaecological cancers: Panel 1
Again, I'm perhaps spending too much time on this, but having that data available helps that argument of why we need—. I will move on, Chair, to perhaps my final question, then: is that the same—we've talked about nurses here—for consultants, for the wider…
, Health and Social Care Committee
Gynaecological cancers: Panel 1
Thank you for that, Chair and Richard. That is positive news. I'm trying to think of a—. I don't want to dampen positive news, especially around Betsi, but that's because, perhaps, the specialist nurse has gone out of her way or his way to give advance notice…
